MUTATIONS OF THE GYRA GENE OF CLINICAL ISOLATES OF SALMONELLA-TYPHIMURIUM AND 3 OTHER SALMONELLA SPECIES LEADING TO DECREASED SUSCEPTIBILITIES TO 4-QUINOLONE DRUGS

Citation
Jc. Brown et al., MUTATIONS OF THE GYRA GENE OF CLINICAL ISOLATES OF SALMONELLA-TYPHIMURIUM AND 3 OTHER SALMONELLA SPECIES LEADING TO DECREASED SUSCEPTIBILITIES TO 4-QUINOLONE DRUGS, Journal of antimicrobial chemotherapy, 37(2), 1996, pp. 351-356
Citations number
11
Categorie Soggetti
Microbiology,"Pharmacology & Pharmacy","Infectious Diseases
ISSN journal
03057453
Volume
37
Issue
2
Year of publication
1996
Pages
351 - 356
Database
ISI
SICI code
0305-7453(1996)37:2<351:MOTGGO>2.0.ZU;2-H
Abstract
The region of the gyrA gene encoding nucleotides 72 to 557 in ten Salm onella typhimurium clinical isolates received from Vellore, India and six British clinical isolates of a number of Salmonella species has be en sequenced. Those exhibiting a decreased susceptibility to 4-quinolo ne drugs (MICs of ciprofloxacin ranging from 0.128 mg/L to 1.0 mg/L) h ave been shown to possess a number of different mutations in this regi on of the gene (Asp-87 to Gly, Asp-87 to Asn and Ser-83 to Phe). The m utations Asp-87 to Gly and Ser-83 to Phe/Asp-87 to Asn have yet to be reported occurring in S. typhimurium.